Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glutamate in neurologic diseases

P Bittigau1, C Ikonomidou

  • 1Department of Pediatric Neurology, Children's Hospital, Humboldt University, Berlin, Germany.

Journal of Child Neurology
|January 16, 1998
PubMed
Summary

Excitotoxicity, driven by excess glutamate, causes neuronal death in brain injuries and neurodegenerative diseases. Targeting this pathway may offer new therapeutic strategies for neurological disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatum.

Amino acids·2013
Same author

Antiepileptic drugs and the developing brain.

Cellular and molecular life sciences : CMLS·2006
Same author

Acute and long-term proteome changes induced by oxidative stress in the developing brain.

Cell death and differentiation·2005
Same author

Modeling pediatric head trauma: mechanisms of degeneration and potential strategies for neuroprotection.

Restorative neurology and neuroscience·2003
Same author

Glutamate signaling and the fetal alcohol syndrome.

Mental retardation and developmental disabilities research reviews·2002
Same author

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.

Journal of neurochemistry·2001

Area of Science:

  • Neuroscience
  • Neurology
  • Cellular Biology

Background:

  • Excitotoxicity is a key mechanism in neuronal death across acute and chronic neurological conditions.
  • Conditions like cerebral ischemia, brain injury, and seizures involve excessive glutamate release, leading to neurotoxicity.
  • Impaired intracellular energy metabolism heightens neuronal susceptibility to glutamate-induced damage.

Purpose of the Study:

  • To explore the role of impaired energy metabolism in excitotoxicity.
  • To investigate the potential of targeting excitotoxicity for treating neurodegenerative diseases.

Main Methods:

  • Review of accumulating evidence on excitotoxicity and energy metabolism.
  • Analysis of the potential therapeutic implications of glutamate antagonists and agents supporting energy metabolism.

Main Results:

  • Glutamate excitotoxicity contributes to neuronal death in various neurological diseases.
  • Slow excitotoxicity, linked to impaired energy metabolism, may play a role in chronic neurodegenerative conditions.
  • Therapeutic strategies could involve glutamate antagonists and agents that improve intracellular energy metabolism.

Conclusions:

  • Excitotoxicity is a significant factor in neuronal death in neurological disorders.
  • Targeting excitotoxicity and enhancing cellular energy metabolism presents a promising therapeutic avenue for neurodegenerative diseases.
  • Combined therapeutic approaches may slow disease progression and improve patient outcomes.

Related Experiment Videos